Mar-01-21 Initiated
Piper Sandler
Overweight
$25
Mar-01-21 Initiated
Oppenheimer
Outperform
$36
Mar-01-21 Initiated
Citigroup
Buy
$30
Mar-01-21 Initiated
Berenberg
Buy
$27
Apr-05-21 08:00AM
Mar-25-21 08:00AM
Mar-22-21 08:00AM
Mar-09-21 08:30AM
Mar-05-21 03:30PM
Feb-10-21 04:55PM
Feb-09-21 11:08AM
Feb-05-21 05:26PM
Feb-04-21 05:56PM
Feb-03-21 08:44PM
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, engages in the discovery and development of therapies with an initial focus on treatments for cancer. The company develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response. It is engineering ImmunoPhage product candidates to directly target antigen presenting cells and modulate the tumor microenvironment through the targeted use of nanobodies which further enhances therapeutic activity. Sensei Biotherapeutics, Inc. was formerly known as Panacea Pharmaceuticals, Inc. The company was founded in 1999 and is headquartered in Rockville, Maryland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Cambrian BioPharma Inc 10% Owner Apr 13 Buy 14.00 2,000 28,000 4,809,544 Apr 14 05:00 PM Peyer James Director Apr 13 Buy 14.00 2,000 28,000 4,809,544 Apr 14 04:41 PM Peyer James Director Apr 07 Buy 14.00 2,000 28,000 4,807,544 Apr 08 06:13 PM Cambrian BioPharma Inc 10% Owner Apr 07 Buy 14.00 2,000 28,000 4,807,544 Apr 08 06:12 PM Cambrian BioPharma Inc 10% Owner Apr 01 Buy 14.00 1,000 14,000 4,805,544 Apr 02 02:58 PM Peyer James Director Apr 01 Buy 14.00 1,000 14,000 4,805,544 Apr 02 02:56 PM Cambrian BioPharma Inc 10% Owner Mar 30 Buy 12.00 2,000 24,000 4,804,544 Mar 31 03:43 PM Peyer James Director Mar 30 Buy 12.00 2,000 24,000 4,804,544 Mar 31 03:41 PM Peyer James Director Mar 24 Buy 14.12 3,750 52,950 4,802,544 Mar 25 12:40 PM Cambrian BioPharma Inc 10% Owner Mar 24 Buy 14.12 3,750 52,950 4,802,544 Mar 25 12:37 PM Peyer James Director Mar 23 Buy 14.34 10,000 143,400 4,798,794 Mar 24 04:21 PM Cambrian BioPharma Inc 10% Owner Mar 23 Buy 14.34 10,000 143,400 4,798,794 Mar 24 04:19 PM Cambrian BioPharma Inc 10% Owner Mar 22 Buy 15.02 2,183 32,789 4,788,794 Mar 23 12:34 PM Peyer James Director Mar 22 Buy 15.02 2,183 32,789 4,788,794 Mar 23 12:32 PM Cambrian BioPharma Inc 10% Owner Mar 18 Buy 15.25 817 12,459 4,786,611 Mar 19 03:51 PM Peyer James Director Mar 18 Buy 15.25 817 12,459 4,786,611 Mar 19 03:44 PM Peyer James Director Mar 08 Buy 15.25 1,000 15,249 4,785,794 Mar 10 05:37 PM Cambrian BioPharma Inc 10% Owner Mar 08 Buy 15.25 1,000 15,249 4,785,794 Mar 10 05:35 PM Cambrian BioPharma Inc 10% Owner Mar 05 Buy 13.75 8,000 110,000 4,784,794 Mar 08 04:55 PM Peyer James Director Mar 05 Buy 13.75 8,000 110,000 4,784,794 Mar 08 04:48 PM Peyer James Director Mar 04 Buy 14.12 2,000 28,250 4,776,794 Mar 05 01:55 PM Cambrian BioPharma Inc 10% Owner Mar 04 Buy 14.12 2,000 28,250 4,776,794 Mar 05 01:57 PM Cambrian BioPharma Inc 10% Owner Mar 03 Buy 15.85 3,000 47,550 4,774,794 Mar 05 01:57 PM Peyer James Director Mar 03 Buy 15.85 3,000 47,550 4,774,794 Mar 05 01:55 PM Peyer James Director Mar 02 Buy 16.25 3,000 48,750 4,771,794 Mar 03 05:22 PM Cambrian BioPharma Inc 10% Owner Mar 02 Buy 16.25 3,000 48,750 4,771,794 Mar 03 05:19 PM Cambrian BioPharma Inc 10% Owner Feb 26 Buy 16.25 5,000 81,250 4,768,794 Mar 02 04:15 PM Peyer James Director Feb 26 Buy 16.25 5,000 81,250 4,768,794 Mar 02 04:15 PM Peyer James Director Feb 25 Buy 15.79 12,000 189,480 4,763,794 Feb 26 04:05 PM Cambrian BioPharma Inc 10% Owner Feb 25 Buy 15.79 12,000 189,480 4,763,794 Feb 26 04:05 PM Cambrian BioPharma Inc 10% Owner Feb 24 Buy 16.91 19,000 321,382 4,751,794 Feb 26 04:05 PM Peyer James Director Feb 24 Buy 16.91 19,000 321,382 4,751,794 Feb 26 04:05 PM Peyer James Director Feb 23 Buy 17.79 20,300 361,070 4,732,794 Feb 25 05:55 PM Cambrian BioPharma Inc 10% Owner Feb 23 Buy 17.79 20,300 361,070 4,732,794 Feb 25 05:55 PM Cambrian BioPharma Inc 10% Owner Feb 22 Buy 18.88 9,802 185,062 4,712,494 Feb 24 08:32 PM Peyer James Director Feb 22 Buy 18.88 9,802 185,062 4,712,494 Feb 24 08:27 PM Cambrian BioPharma Inc 10% Owner Feb 19 Buy 19.77 11,786 233,009 4,702,692 Feb 23 04:15 PM Peyer James Director Feb 19 Buy 19.77 11,786 233,009 4,702,692 Feb 23 04:15 PM Cambrian BioPharma Inc 10% Owner Feb 18 Buy 19.75 753 14,872 4,690,906 Feb 19 04:15 PM Peyer James Director Feb 18 Buy 19.75 753 14,872 4,690,906 Feb 19 04:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite